Active — Not RecruitingNot Applicable

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

Sweden400 participantsStarted 2019-01-10

Plain-language summary

A randomized controlled trial to evaluate which treatment protocol in selective laser trabeculoplasty that is most optimal in terms of efficacy and safety.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis primary open-angle glaucoma, pseudo-exfoliative glaucoma or ocular hypertension. * intra-ocular pressure (IOP) at least 18 mmHg treatment day. * treatment is performed by an experienced laser surgeon. * SLT treatment and follow-up are expected to be possible to perform in an adequate way, considering anatomical factors, age and the general health of the patient. Exclusion Criteria: * change of IOP-lowering medication during the last three months. * planned change of intra-ocular-pressure-lowering medication. * previous glaucoma surgery (other than SLT and ALT) * previous intra-ocular surgery during the last three months. * previous intra-ocular inflammatory disease during the last year. * planned intra-ocular surgery. * hyper-pigmented anterior chamber angle.

What they're measuring

Change in intraocular pressure (IOP)

Timeframe: Before SLT and thereafter regularly for 3 years

Achievement of 20% reduction in IOP

Timeframe: For 3 years

Survival (no additional intervention)

Timeframe: For 3 years

Trial details

NCT IDNCT03798223

SponsorVastra Gotaland Region

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2027-12-31

View on ClinicalTrials.gov More Glaucoma, Open-Angle trials